Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy.
| Autor: | Zhao XH; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Shen WB; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Wang D; Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China., Wang HS; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Song CY; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Deng WZ; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in oncology [Front Oncol] 2023 Dec 12; Vol. 13, pp. 1347301. Date of Electronic Publication: 2023 Dec 12 (Print Publication: 2023). |
| DOI: | 10.3389/fonc.2023.1347301 |
| Abstrakt: | [This corrects the article DOI: 10.3389/fonc.2023.1167625.]. (Copyright © 2023 Zhao, Shen, Wang, Wang, Song and Deng.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|